Skip to content

    Cancer Health Center

    Font Size

    Depression (PDQ®): Supportive care - Health Professional Information [NCI] - Intervention

    Table 2. Antidepressant Medications for Ambulatory Adult Patients continued...


    Benzodiazepines can be used to effectively treat the anxiety that may be associated with depression. In patients receiving antidepressant medications and benzodiazepines concomitantly, the latter drugs may be discontinued after patients' depressive symptoms begin to abate; however, both agents can be continued safely if needed. Benzodiazepines should never be stopped abruptly because withdrawal symptoms with possible seizures may occur. The dose of benzodiazepines should be tapered slowly at a rate of approximately 25% every 3 to 4 days.


    Clinical experience (see Table 3) suggests that analeptic agents (e.g., methylphenidate and dextroamphetamine) are useful at low doses for patients whose symptoms include depressed mood, apathy, decreased energy, poor concentration, and weakness.[36][Level of evidence: II] They are particularly useful for patients with advanced cancer who have a limited life expectancy (weeks to a few months). Compared with traditional antidepressants such as the TCAs and SSRIs that take 3 to 4 weeks to take effect, the psychostimulants often demonstrate antidepressant effects within a few days of starting treatment. They promote a sense of well-being, decreased fatigue, and increased appetite. Analeptic agents can be helpful in countering the sedating effects of opioids, and in comparison with antidepressants, they are rapidly effective. Adverse effects associated with analeptic agents include insomnia, euphoria, and mood lability. High doses and long-term use may produce anorexia, nightmares, insomnia, euphoria, or paranoia.

    Methylphenidate and dextroamphetamine are administered in divided doses early in a patient's waking cycle to avoid sleep disturbances (e.g., insomnia and nighttime arousal). Like benzodiazepines, these medications are adjuncts to antidepressant medications; they may be started concomitant with an antidepressant and discontinued when depressive symptoms abate.[37,38]

    Table 3. Clinical Trials of Psychostimulants in Cancer Patients

    Study Comments Drug(s) Outcome
    Meyers et al. 1998[39] Brain tumor; N = 30 methylphenidate (Ritalin) ↑ mood, ↑ cognition, ↑ function
    Olin and Masand 1996[40] Mixed cancer; N = 59; chart review dextroamphetamine (Dexedrine); methylphenidate (Ritalin) ↓ depression, ↑ appetite
    Bruera et al. 1992[41] Cancer pain vs. opioid infusion; N = 20 methylphenidate (Ritalin); placebo ↑ cognition, ↓ sedation
    Fernandez et al. 1987[38] Mixed cancer; rapid onset; N = 30 methylphenidate (Ritalin; up to 80 mg) ↓ depression
    Bruera et al. 1986[42] Pain; double-blind cross-over study; N = 24 mazindol (Mazanor) ↓ pain, ↓ appetite, no effect on mood
    Joshi et al. 1982[43] Terminally ill amphetamine ↑ comfort
    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16
    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16
    Next Article:

    Today on WebMD

    man holding lung xray
    What you need to know.
    stem cells
    How they work for blood cancers.
    woman wearing pink ribbon
    Separate fact from fiction.
    Colorectal cancer cells
    Symptoms, screening tests, and more.
    Jennifer Goodman Linn self-portrait
    what is your cancer risk
    colorectal cancer treatment advances
    breast cancer overview slideshow
    prostate cancer overview
    lung cancer overview slideshow
    ovarian cancer overview slideshow
    Actor Michael Douglas